Inhibition of STAT Pathway Impairs Anti-Hepatitis C Virus Effect of Interferon Alpha

Cellular Physiology and Biochemistry

Volumn 40, Issue 1-2, 2016, Pages 77-90

  Zhao, Lan Juan ^a   He, Sheng Fei ^a   Liu, Yuan ^a,c   Zhao, Ping ^a   Bian, Zhong Qi ^b   Qi, Zhong Tian ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b KUNMING GENERAL HOSPITAL   (China)

^c General Hospital of the Chengdu Military Command   (China)

Author keywords

Hepatitis C virus; Interferon; Interferon alpha receptor; Signal transducer and activator of transcription

Indexed keywords

ALPHA INTERFERON; MONOCLONAL ANTIBODY; STAT PROTEIN; STAT1 PROTEIN; STAT2 PROTEIN; INTERFERON RECEPTOR; JANUS KINASE; PROTEIN KINASE INHIBITOR; STAT1 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; HEPATITIS C; HEPATITIS C VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION; VIRUS REPLICATION; ANTAGONISTS AND INHIBITORS; CELL SURVIVAL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENE SILENCING; HEPACIVIRUS; KINETICS; METABOLISM; PATHOLOGY; PHOSPHORYLATION; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL SURVIVAL; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERON-ALPHA; JANUS KINASES; KINETICS; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; RECEPTORS, INTERFERON; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STAT2 TRANSCRIPTION FACTOR;

EID: 84997251081     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000452526     Document Type: Article

References (36)

1. Levy DE, Darnell JE Jr: Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 2002;3:651-662.
2. Schindler C, Levy DE, Decker T: JAK-STAT signaling: from interferons to cytokines. J Biol Chem 2007;282:20059-20063.
3. Katze MG, He Y, Gale MJr: Viruses and interferon: a fight for supremacy. Nat Rev Immunol 2002;2:675-687.
4. Sadler AJ, Williams BR: Interferon-inducible antiviral effectors. Nat Rev Immunol 2008;8:559-568.
5. Younossi ZM, Baranova A, Afendy A, Collantes R, Stepanova M, Manyam G, Bakshi A, Sigua CL, Chan JP, Iverson AA, Santini CD, Chang SY: Early gene expression profiles of patients with chronic hepatitis C treated with pegylated interferon-alfa and ribavirin. Hepatology 2009;49:763-774.
6. Delang L, Coelmont L, Neyts J: Antiviral therapy for hepatitis C virus: beyond the standard of care. Viruses 2010;2:826-866.
7. Marcello T, Grakoui A, Barba-Spaeth G, Machlin ES, Kotenko SV, MacDonald MR, Rice CM: Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics. Gastroenterology 2006;131:1887-1898.
8. Hazari S, Chandra PK, Poat B, Datta S, Garry RF, Foster TP, Kousoulas G, Wakita T, Dash S: Impaired antiviral activity of interferon alpha against hepatitis C virus 2a in Huh-7 cells with a defective Jak-Stat pathway. Virol J 2010;7:36.
9. Dubois A, François C, Descamps V, Fournier C, Wychowski C, Dubuisson J, Castelain S, Duverlie G: Enhanced anti-HCV activity of interferon alpha 17 subtype. Virol J 2009;6:70.
10. Datta S, Hazari S, Chandra PK, Samara M, Poat B, Gunduz F, Wimley WC, Hauser H, Koster M, Lamaze C, Balart LA, Garry RF, Dash S: Mechanism of HCV's resistance to IFN-α in cell culture involves expression of functional IFN-α receptor 1. Virol J 2011;8:351.
11. Sarasin-Filipowicz M, Oakeley EJ, Duong FH, Christen V, Terracciano L, Filipowicz W, Heim MH: Interferon signaling and treatment outcome in chronic hepatitis C. Proc Natl Acad Sci USA 2008;105:7034-7039.
12. Miyagi T, Takehara T, Nishio K, Shimizu S, Kohga K, Li W, Tatsumi T, Hiramatsu N, Kanto T, Hayashi N: Altered interferon-alpha-signaling in natural killer cells from patients with chronic hepatitis C virus infection. J Hepatol 2010;53:424-430.
13. Zhao LJ, Wang W, Liu Y, Ren H, Qi ZT: Interference with ERK and STAT signaling pathways and inhibition of hepatitis C virus replication by ribavirin. Antivir Res 2012;96:260-268.
14. He SF, Wang W, Ren H, Zhao LJ, Qi ZT: Interferon alpha and ribavirin collaboratively regulate p38 mitogen-activated protein kinase signaling in hepatoma cells. Cytokine 2013;61:801-807.
15. Heim MH: Intracellular signalling and antiviral effects of interferons. Dig Liver Dis 2000;32:257-263.
16. David M: Signal transduction by type I interferons. Biotechniques 2002;(Suppl):58-65.
17. Morita K, Tanaka K, Saito S, Kitamura T, Kiba T, Fujii T, Numata K, Sekihara H: Expression of interferon receptor genes in the liver as a predictor of interferon response in patients with chronic hepatitis C. J Med Virol 1999;58:359-365.
18. Yatsuhashi H, Fujino T, Matsumoto T, Inoue O, Koga M, Yano M: Immunohistochemical analysis of hepatic interferon alpha-beta receptor level: relationship between receptor expression and response to interferon therapy in patients with chronic hepatitis C. J Hepatol 1999;30:995-1003.
19. Larrea E, Aldabe R, Molano E, Fernandez-Rodriguez CM, Ametzazurra A, Civeira MP, Prieto J: Altered expression and activation of signal transducers and activators of transcription (STATs) in hepatitis C virus infection: in vivo and in vitro studies. Gut 2006; 55:1188-1196.
20. Xue J, Chen F, Wang J, Wu S, Zheng M, Zhu H, Liu Y, He J, Chen Z: Emodin protects against concanavalin A-induced hepatitis in mice through inhibiting activation of the p38 MAPK-NF-κB signaling pathway. Cell Physiol Biochem 2015;35:1557-1570.
21. Zhou C, Jin X, Tang J, Fei J, Gu C, Chen X: Association of CD40-1C/T polymorphism in the 5'-untranslated region with chronic HBV infection. Cell Physiol Biochem 2015;35:83-91.
22. Abendroth A, Slobedman B, Lee E, Mellins E, Wallace M, Arvin AM: Modulation of major histocompatibility class II protein expression by varicella-zoster virus. J Virol 2000;74:1900-1907.
23. Ramaswamy M, Shi L, Monick MM, Hunninghake GW, Look DC: Specific inhibition of type I interferon signal transduction by respiratory syncytial virus. Am J Respir Cell Mol Biol 2004;30:893-900.
24. Stevenson NJ, Bourke NM, Ryan EJ, Binder M, Fanning L, Johnston JA, Hegarty JE, Long A, O'Farrelly C: Hepatitis C virus targets the interferon-α JAK/STAT pathway by promoting proteasomal degradation in immune cells and hepatocytes. FEBS Lett 2013;587:1571-1578.
25. Pugnale P, Pazienza V, Guilloux K, Negro F: Hepatitis delta virus inhibits alpha interferon signaling. Hepatology 2009;49:398-406.
26. Valmas C, Grosch MN, Schümann M, Olejnik J, Martinez O, Best SM, Krähling V, Basler CF, Mühlberger E: Marburg virus evades interferon responses by a mechanism distinct from ebola virus. PLoS Pathog 2010;6:e1000721.
27. Dong C, Zafrullah M, Mixson-Hayden T, Dai X, Liang J, Meng J, Kamili S: Suppression of interferon-α signaling by hepatitis E virus. Hepatology 2012;55:1324-1332.
28. Heim MH, Moradpour D, Blum HE: Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway. J Virol 1999;73:8469-8475.
29. Blindenbacher A, Duong FH, Hunziker L, Stutvoet ST, Wang X, Terracciano L, Moradpour D, Blum HE, Alonzi T, Tripodi M, La Monica N, Heim MH: Expression of hepatitis C virus proteins inhibits interferon alpha signaling in the liver of transgenic mice. Gastroenterology 2003;124:1465-1475.
30. Moerdyk-Schauwecker M, Shah NR, Murphy AM, Hastie E, Mukherjee P, Grdzelishvili VZ: Resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus: role of type I interferon signaling. Virology 2013;436:221-234.
31. Zhang L, Jilg N, Shao RX, Lin W, Fusco DN, Zhao H, Goto K, Peng LF, Chen WC, Chung RT: IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway. J Hepatol 2011;55:289-298.
32. Matsumoto A, Ichikawa T, Nakao K, Miyaaki H, Hirano K, Fujimito M, Akiyama M, Miuma S, Ozawa E, Shibata H, Takeshita S, Yamasaki H, Ikeda M, Kato N, Eguchi K: Interferon-alpha-induced mTOR activation is an anti-hepatitis C virus signal via the phosphatidylinositol 3-kinase-Akt-independent pathway. J Gastroenterol 2009;44:856-863.
33. Xia C, Liu Y, Chen Z, Zheng M: Involvement of interleukin 6 in hepatitis B viral infection. Cell Physiol Biochem 2015;37:677-686.
34. Lin RJ, Liao CL, Lin E, Lin YL: Blocking of the alpha interferon-induced Jak-Stat signaling pathway by Japanese encephalitis virus infection. J Virol 2004;78:9285-9294.
35. Thomas E, Feld JJ, Li Q, Hu Z, Fried MW, Liang TJ: Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture models. Hepatology 2011;53:32-41.
36. Liu MQ, Zhou DJ, Wang X, Zhou W, Ye L, Li JL, Wang YZ, Ho WZ: IFN-λ3 inhibits HIV infection of macrophages through the JAK-STAT pathway. PLoS One 2012;7:e35902.